Articles On CogState (ASX:CGS)

Investors in Melbourne-based digital cognitive assessment technology company Cogstate (ASX: CGS) received a serious dopamine hit today, after the company's partners received accelerated approval overnight for the Alzheimer's drug aducanumab...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,270.7 points. Four ASX shares that are not letting that hold them back today are...

Summary Dateline Resources has reported the second phase of ore sorting results for the Gold Links Gold Mine. Mad Paws has added 10K new customers from March to May. Aeris Resources’ share price has marked a new 52-week high of AU$0.2...

Cogstate (ASX:CGS) has become the latest ASX health stock to gain from an FDA green light even though it is only indirectly involved – right now. Overnight the US regulator approved the first Alzheimer’s therapy since 2003 and the first dru...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The Cogstate Limited (ASX: CGS) share price is rocketing higher on Tuesday morning. At the time of writing, the neuroscience technology company’s shares are up 73% to $1.60. Why is the Cogstate share price rocketing higher? Investors have...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It has been...

The ASX quarterly earnings season is in full full swing. With so many releases every day, it’s easy for investors to miss what’s been happening, let alone identify winners from the losers. Stockhead has summarised a list of 8 small caps tha...

The CogState Limited (ASX: CGS) share price is currently rising as the company announced a business update to the market. Shares in the small cap healthcare company are currently rising by 5.82%. This takes the Cogstate share price to $1.0...

CogState Limited (ASX: CGS) shares performed well today after the company released its second quarterly report for FY21. At the market’s close, the CogState share price was trading 8.3% higher at $1.105.  What drove the CogState share pric...

Summary Medibio Limited disclosed that its sleep staging software, MEBsleep, has obtained CE Mark approval. With the CE Mark, the health technology player can accelerate MEBsleep commercialisation activities in the EEC. The Company is...

The Cogstate Limited (ASX: CGS) share price has been fluctuating today after the company released a business update to the ASX. Earlier today the Cogstate share price was trading 2.33% higher but has now dipped into the red and is down by...

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

The CogState Limited (ASX: CGS) share price is going ballistic today, up 44% at the time of writing. This will come as more good news to longer-term shareholders, who’ve seen the share price rocket 207% since the closing bell on 31 Decembe...

ShareCafeHidden Gems Webinar Recap – VMS, CGS, MHC, DSK   Catch up on the full webinar with presentations from Venture Minerals (ASX: VMS), Cogstate Limited (ASX: CGS), Manhattan Corporation (ASX: MHC) and Dusk Group Limited (ASX:DSK). Hid...

ShareCafeCogstate Limited (ASX: CGS) – Hidden Gems Webinar Presentation   Presenter – Brad O’Connor – CEO & MD – Founded in 1999 and listed on the Australian Securities Exchange in 2004, Cogstate (ASX.CGS) is a world-class neuroscience...

The CogState Limited (ASX: CGS) share price has surged up 24.7% at the time of writing to $1.34 a share after closing at $1.09 yesterday and opening at $1.15 this morning. This move represents a continuation of the stellar year Cogstate sh...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down a sizeable 1.4% to 6,071.1 points. Four shares that have not let that hold th...

The CogState Limited (ASX: CGS) share price has been an exceptionally strong performer on Monday. At the time of writing, the neuroscience technology company’s shares are up a massive 36% to a 52-week high of $1.08. Why is the CogState sha...

Mental health stocks set to benefit from increased mental health awareness This week’s budget included measures to help patients and the sector Cogstate (ASX:CGS) is 2020’s biggest winner so far up over 50 per cent As the world becomes i...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Scott Powe...

The Cogstate Limited (ASX: CGS) share price ripped more than 78% higher in early trade after the company released its quarterly cash flow statement and business update. It has since been sold down and is currently trading 30.95% higher at...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim chats with Brad O’Connor, managing director and C...

Neuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it has executed $9.1m of clinical trials sales contracts since the start of 2020. The stock — up about 30 per cent on the news — says this revenu...

Dementia already affects hundreds of thousands of people in Australia, and it’s only going to get worse if a medical miracle is not forthcoming. The term relates to brain diseases, including Alzheimers, that impact a person’s ability to thi...

You may have heard the saying “it’s not brain surgery” in the context of trying to prove something easy. Well there is a reason  — our brains are among the most difficult parts of our body to treat. There are a few ASX small caps trying to...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.16% to 6...

The CogState Limited (ASX: CGS) share price surged after the brain health testing company reported a record level of sales contracts. The CGS share price jumped 30% to 39 cents during lunch time trade when the All Ordinaries (Index:^AORD)...

Neuroscience technology company Cogstate (CGS), has achieved an additional $19.1 million of clinical trials sales contracts so far this quarter The total value of contracts executed since July 1st is $26.8 million, which is the best half y...

Neuroscience technology company Cogstate (ASX: CGS) revealed it has executed US$26.8 million (A$38.88 million) in clinical trial sales contracts for the 2020 financial year to date – making it the company’s best half year result on record....

Penny stocks may just sound penny but can possibly land the investor in a lifetime’s fortune. The penny stocks/shares in which you invest might not be as penny in terms of their return potential as it might simply sound. Here, we shall focu...

Last week it was former Hawthorn president Andrew Newbold who took a big leap of faith in his firm; this week it was former AFL commissioner Mike Fitzpatrick. He is on the board of Carnegie Clean Energy (ASX:CCE), which was finally recapita...

Getting traction has taken time. But for the likes of Cogstate (ASX:CGS) and Total Brain (ASX:TTB), which have developed online mental health programs, deals with partners boasting deep pockets have begun to flow. This is giving management...

Penny Stocks Penny stocks are those stocks that trade at a low price of less than $1. These stocks also have a small market cap and are speculative in nature. Trading in penny stocks involves a lot of risks. Thus, before making any investme...

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in th...

In this week’s recap of substantial shareholders, IOOF and a UK hedge fund manager take a bet they’ll recoup their losses in Speedcast (ASX:SDA), Australian Ethical Investment buys a 16 per cent stake in Cogstate (ASX:CGS) and Taurus increa...